Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 82 Records) |
| Query Trace: Myelodysplastic Syndromes and TP53[original query] |
|---|
| Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia. International journal of molecular sciences 2021 9 22 (18): . Cluzeau Thomas, Loschi Michael, Fenaux Pierre, Komrokji Rami, Sallman David |
| Molecular Characterization and Clinical Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Patients With TP53 Mutation. Clinical lymphoma, myeloma & leukemia 2021 8 21 (12): 841-851. Li Yanfen, Wan Hua, Jing |
| Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. British journal of haematology 2021 7 194 (4): 708-717. Martín Iván, Villamón Eva, Abellán Rosario, Calasanz Maria José, Irigoyen Aroa, Sanz Guillermo, Such Esperanza, Mora Elvira, Gutiérrez Míriam, Collado Rosa, García-Serra Rocío, Vara Míriam, Blanco Mª Laura, Oiartzabal Itziar, Álvarez Sara, Bernal Teresa, Granada Isabel, Xicoy Blanca, Jerez Andrés, Calabuig Marisa, Diez Rosana, Gil Ángela, Díez-Campelo María, Solano Carlos, Tormo Mar, |
| The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm. International journal of laboratory hematology 2021 7 43 (6): 1501-1509. Ibrar Warda, Zhang Weiwei, Cox Jesse Lee, Cushman-Vokoun Allison, Fu Kai, Greiner Timothy C, Yuan |
| [Characteristics and Clinical Significance of Gene Mutation in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2021 12 29 (6): 1864-1868. Zhao Fang, Wang Kai-Li, Qin Yu-Ting, Nilupar Tuerxun, Patiguli Abulizi, Jiang Ming, Hao Jian-Pi |
| Have we reached a molecular era in myelodysplastic syndromes? Hematology. American Society of Hematology. Education Program 2021 12 2021 (1): 418-427. Voso Maria Teresa, Gurnari Carme |
| TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes. Cancers 2021 11 13 (21): . Yabe Mariko, Omarbekova Aidana Z, Hsu Meier, May Hannah, Arcila Maria E, Liu Ying, Dogan Ahmet, Brunner Andrew M, Nardi Valentina, Hasserjian Robert P, Klimek Virginia |
| A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes. Blood advances 2021 Oct . Wang Yu-Hung, Hou Hsin-An, Lin Chien-Chin, Kuo Yuan-Yeh, Yao Chi-Yuan, Hsu Chia-Lang, Tseng Mei-Hsuan, Tsai Cheng-Hong, Peng Yen-Ling, Kao Chein-Jun, Chou Wen-Chien, Tien Hwei-Fa |
| Clinical Characteristics, Prognosis, and Treatment Strategies of TP53 Mutations in Myelodysplastic Syndromes. Clinical lymphoma, myeloma & leukemia 2021 10 22 (4): 224-235. Fang Kun, Qi Jiaqian, Zhou Meng, Zhang Ziyan, Han Y |
| Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes. British journal of haematology 2022 6 198 (4): 713-720. Volpe Virginia O, Al Ali Najla, Chan Onyee, Padron Eric, Sallman David A, Kuykendall Andrew, Sweet Kendra, Lancet Jeffrey E, Komrokji Rami |
| De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features. Leukemia research 2022 Jun 117 106857. Epstein-Peterson Zachary D, Spitzer Barbara, Derkach Andriy, Arango Juan E, McCarter Joseph G W, Medina-Martínez Juan S, McGovern Erin, Farnoud Noushin Rahnamay, Levine Ross L, Tallman Martin |
| Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Scientific reports 2022 4 12 (1): 5925. Maurya Nehakumari, Mohanty Purvi, Dhangar Somprakash, Panchal Purvi, Jijina Farah, Mathan S Leo Prince, Shanmukhaiah Chandrakala, Madkaikar Manisha, Vundinti Babu R |
| Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes. BMC cancer 2022 Jan 22 (1): 127. Shi Cong, Gong Shengping, Wu An, Yang Shujun, Zou Duobing, Zhang Yi, Wu Ningning, Ma Chao, Shi Songqiu, Chen Ying, Wu Ying, Zheng Xiaojiao, Huang Zhenya, Ding Jianghua, Ouyang Guifang, Mu Qiti |
| Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS). Clinical lymphoma, myeloma & leukemia 2022 2 22 (7): e467-e476. Chan Onyee, Ali Najla Al, Sallman David, Padron Eric, Lancet Jeffrey, Komrokji Ra |
| Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. Hematological oncology 2022 11 . Lee Wan-Hsuan, Lin Chien-Chin, Wang Yu-Hung, Yao Chi-Yuan, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Hsu Cheng-An, Sun Hsun-I, Chuang Yi-Kuang, Hsu Chia-Lang, Tien Feng-Ming, Tsai Cheng-Hong, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
| Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood 2022 11 141 (5): 534-549. Makishima Hideki, Saiki Ryunosuke, Nannya Yasuhito, Korotev Sophia, Gurnari Carmelo, Takeda June, Momozawa Yukihide, Best Steve, Krishnamurthy Pramila, Yoshizato Tetsuichi, Atsuta Yoshiko, Shiozawa Yusuke, Iijima-Yamashita Yuka, Yoshida Kenichi, Shiraishi Yuichi, Nagata Yasunobu, Kakiuchi Nobuyuki, Onizuka Makoto, Chiba Kenichi, Tanaka Hiroko, Kon Ayana, Ochi Yotaro, Nakagawa Masahiro M, Okuda Rurika, Mori Takuto, Yoda Akinori, Itonaga Hidehiro, Miyazaki Yasushi, Sanada Masashi, Ishikawa Takayuki, Chiba Shigeru, Tsurumi Hisashi, Kasahara Senji, Müller-Tidow Carsten, Takaori-Kondo Akifumi, Ohyashiki Kazuma, Kiguchi Toru, Matsuda Fumihiko, Jansen Joop H, Polprasert Chantana, Blombery Piers, Kamatani Yoichiro, Miyano Satoru, Malcovati Luca, Haferlach Torsten, Kubo Michiaki, Cazzola Mario, Kulasekararaj Austin G, Godley Lucy A, Maciejewski Jaroslaw P, Ogawa Seis |
| IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons???60 years with myelodysplastic syndromes. Experimental hematology & oncology 2022 Oct 11 (1): 73. Wu Junying, Zhang Yudi, Qin Tiejun, Xu Zefeng, Qu Shiqiang, Pan Lijuan, Li Bing, Jia Yujiao, Li Chengwen, Wang Huijun, Gao Qingyan, Cai Wenyu, Gong Jingye, Zhao Songyang, Li Fuhui, Gale Robert Peter, Xiao Zhiji |
| Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations. Annals of hematology 2022 Jan . Dutta Sayantanee, Moritz Jennifer, Pregartner Gudrun, Thallinger Gerhard G, Brandstätter Ilona, Lind Karin, Rezania Simin, Lyssy Freya, Reinisch Andreas, Zebisch Armin, Berghold Andrea, Wölfler Albert, Sill Hei |
| TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML. Blood advances 2022 Jan . Weinberg Olga K, Siddon Alexa, Madanat Yazan F, Gagan Jeffrey, Arber Daniel A, Dal Cin Paola, Narayanan Damodaran, Ouseph Madhu M, Kurzer Jason H, Hasserjian Robert |
| Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes. Journal of cancer research and clinical oncology 2022 1 148 (4): 845-856. Jiang Lingxu, Ye Li, Ma Liya, Ren Yanling, Zhou Xinping, Mei Chen, Xu Gaixiang, Yang Haiyang, Lu Chenxi, Luo Yingwan, Zhu Shuanghong, Wang Lu, Shen Chuying, Yang Wenli, Zhang Qi, Wang Yuxia, Lang Wei, Han Yueyuan, Jin Jie, Tong Hongy |
| Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants. American journal of hematology 2023 9 . Alex Bataller, Sanam Loghavi, Yoheved Gerstein, Alexandre Bazinet, Koji Sasaki, Kelly S Chien, Danielle Hammond, Guillermo Montalban-Bravo, Gautam Borthakur, Nicholas Short, Ghayas C Issa, Tapan M Kadia, Naval Daver, Guilin Tang, Andres Quesada, Keyur P Patel, Farhad Ravandi, Warren Fiskus, Cristopher P Mill, Hagop M Kantarjian, Kapil Bhalla, Guillermo Garcia-Manero, Betul Oran, Courtney D DiNar |
| U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
| Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile. Annals of hematology 2023 8 . Luca Guarnera, Emiliano Fabiani, Cristina Attrotto, Hajro Hajrullaj, Antonio Cristiano, Roberto Latagliata, Susanna Fenu, Francesco Buccisano, Maria Irno-Consalvo, Consuelo Conti, Maria Teresa Voso, Luca Mauril |
| A Randomised Comparison of CPX-351 and FLAG-Ida in Adverse Karyotype AML and High-Risk MDS: The UK NCRI AML19 Trial. Blood advances 2023 5 . Jad Othman, Charlotte S Wilhelm-Benartzi, Richard Dillon, Steven Knapper, Sylvie D Freeman, Leona M Batten, Joanna Canham, Emily L Hinson, Julie Wych, Sophie Betteridge, William Villiers, Michelle Kleeman, Amanda Frances Gilkes, Nicola Potter, Ulrik Overgaard, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Jane Hemmaway, Claire Arnold, Mike Dennis, Nigel H Russe |
| Clinical implications of myeloid malignancy?related somatic mutations in aplastic anemia. Clinical and experimental medicine 2023 4 . Lingling Liu, Danfeng Zhang, Qiuhao Fu, Jingdi Wang, Jifeng Yu, Dandan Chen, Fang Wang, Rong Guo, Xinsheng Xie, Zhongxing Jiang, Yingmei |
| Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study. Journal of hematology & oncology 2023 4 16 (1): 37. Zhang Tao, Auer Paul, Dong Jing, Cutler Corey, Dezern Amy E, Gadalla Shahinaz M, Deeg H Joachim, Nazha Aziz, Carlson Karen-Sue, Spellman Stephen, Bolon Yung-Tsi, Saber Wa |
| Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes. Hematology (Amsterdam, Netherlands) 2023 3 28 (1): 2181773. Zhang Lijuan, Chen Kankan, Li Yingying, Chen Qiuni, Shi Wenting, Ji Tingting, Tao Hong, He Zhengmei, Wang Chunling, Yu Lia |
| Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes. Leukemia & lymphoma 2023 10 1-9. Youshan Zhao, Juan Guo, Sida Zhao, Roujia Wang, Dong Wu, Chunkang Cha |
| Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53. Clinics in laboratory medicine 2023 10 43 (4): 607-614. Alexa J Siddon, Olga K Weinbe |
| [Risk factors for leukemia transformation in patients with myelodysplastic syndromes]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (10): 818-825. Zhao S Y, Xu Z F, Qin T J, Qu S Q, Li C W, Jia Y J, Pan L J, Li B, Gao Q Y, Jiao M, Huang H J, Xiao Z |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: